{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-24T04:48:05.383419+00:00","published_at":"2026-10-24T04:48:05.383419+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:hpnx2ak3jp26","event_type":"CEO_CHANGED","effective_at":"2026-04-30","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:brian-m-strem-ph-d","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:434fefa119fd890d6372a79e5b99737e46e8ce5c412af8804f4ee76ba9ee3f7f"],"summary":"Brian M. Strem, Ph.D. executive of KIORA PHARMACEUTICALS INC, effective 2026-04-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ew5df71wj7zw9","event_type":"CFO_CHANGED","effective_at":"2026-04-30","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:melissa-tosca-cpa","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:1869ac78a81b79697eb5de31e480aa9c176f6c7836cf74af0bd0e032f9202402"],"summary":"Melissa Tosca, CPA executive of KIORA PHARMACEUTICALS INC, effective 2026-04-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1oy1gh81mdbyci","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:lisa-walters-hoffert","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Lisa Walters-Hoffert seat on KIORA PHARMACEUTICALS INC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1i4cof0rf3uqi","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:committee:kiora-pharmaceuticals-inc:audit-chair-compensation","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Audit · Chair; Compensation committee of KIORA PHARMACEUTICALS INC, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lkqa9o1v0qwbq","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:lisa-walters-hoffert","alpha:committee:kiora-pharmaceuticals-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Lisa Walters-Hoffert member of Audit · Chair; Compensation, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mqb6q7viqmuf","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:carmine-stengone","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Carmine N. Stengone seat on KIORA PHARMACEUTICALS INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uhvkg1yqbd11","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:carmine-stengone","alpha:committee:kiora-pharmaceuticals-inc:audit"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:14"],"evidence_ids":["alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf"],"summary":"Carmine N. Stengone member of Audit, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:gb5psg1c0slew","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:erin-parsons","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Erin Parsons seat on KIORA PHARMACEUTICALS INC, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hq5o0rb6vwo","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:committee:kiora-pharmaceuticals-inc:compensation-chair-nominating-and-governance","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Compensation · Chair; Nominating and Governance committee of KIORA PHARMACEUTICALS INC, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1i5vtyq18pywl6","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:erin-parsons","alpha:committee:kiora-pharmaceuticals-inc:compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Erin Parsons member of Compensation · Chair; Nominating and Governance, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:j8rodv8a6tzr","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:aron-shapiro","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Aron Shapiro seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:wxnv3iq83ti0","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:brian-m-strem-ph-d","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Brian M. Strem, Ph.D. seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mvj03w1gkqeeu","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:david-hollander-md-mba","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"David Hollander, MD, MBA seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:147blrm1s5zq5m","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:committee:kiora-pharmaceuticals-inc:nominating-and-governance-chair","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Nominating and Governance · Chair committee of KIORA PHARMACEUTICALS INC, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rt3x6n1e27rl1","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:david-hollander-md-mba","alpha:committee:kiora-pharmaceuticals-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"David Hollander, MD, MBA member of Nominating and Governance · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9x7g2vb3z8g5","event_type":"DIRECTOR_APPOINTED","effective_at":"2008-01-01","detected_at":"2026-10-24T04:48:05.383419+00:00","subject_ids":["alpha:person:praveen-tyle-ph-d","alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575"],"caused_claim_ids":["alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49"],"summary":"Praveen Tyle, Ph.D. seat on KIORA PHARMACEUTICALS INC, effective 2008-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:5","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:aron-shapiro","object_label":"Aron Shapiro","object_source_name_forms":[],"value":"Aron Shapiro: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:aron-shapiro","name":"Aron Shapiro"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:6","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:brian-m-strem-ph-d","object_label":"Brian M. Strem, Ph.D.","object_source_name_forms":[],"value":"Brian M. Strem, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:brian-m-strem-ph-d","name":"Brian M. Strem, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:7","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carmine-stengone","object_label":"Carmine N. Stengone","object_source_name_forms":[],"value":"Carmine N. Stengone: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:carmine-stengone","name":"Carmine N. Stengone"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:8","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-hollander-md-mba","object_label":"David Hollander, MD, MBA","object_source_name_forms":[],"value":"David Hollander, MD, MBA: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-hollander-md-mba","name":"David Hollander, MD, MBA"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:9","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:erin-parsons","object_label":"Erin Parsons","object_source_name_forms":[],"value":"Erin Parsons: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:erin-parsons","name":"Erin Parsons"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:10","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lisa-walters-hoffert","object_label":"Lisa Walters-Hoffert","object_source_name_forms":[],"value":"Lisa Walters-Hoffert: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lisa-walters-hoffert","name":"Lisa Walters-Hoffert"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:11","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:praveen-tyle-ph-d","object_label":"Praveen Tyle, Ph.D.","object_source_name_forms":[],"value":"Praveen Tyle, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:praveen-tyle-ph-d","name":"Praveen Tyle, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2008-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2008-01-01","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2008-01-01","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:12","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brian-m-strem-ph-d","object_label":"Brian M. Strem, Ph.D.","object_source_name_forms":[],"value":"Brian M. Strem, Ph.D.: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:brian-m-strem-ph-d","name":"Brian M. Strem, Ph.D."},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-30","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:434fefa119fd890d6372a79e5b99737e46e8ce5c412af8804f4ee76ba9ee3f7f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000040/kprx-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T04:34:48.081955+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-30T00:00:00+00:00","effective_from":"2026-04-30","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:13","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:melissa-tosca-cpa","object_label":"Melissa Tosca, CPA","object_source_name_forms":[],"value":"Melissa Tosca, CPA: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:melissa-tosca-cpa","name":"Melissa Tosca, CPA"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-30","valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:document:1869ac78a81b79697eb5de31e480aa9c176f6c7836cf74af0bd0e032f9202402","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000040/kprx-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T04:34:48.709709+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-30T00:00:00+00:00","effective_from":"2026-04-30","effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:14","subject_id":"alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Lisa Walters-Hoffert; Members Lisa Walters-Hoffert (Chair); Carmine N. Stengone","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Lisa Walters-Hoffert","members":[{"display_name":"Lisa Walters-Hoffert","person_slug":"lisa-walters-hoffert","is_chair":true},{"display_name":"Carmine N. Stengone","person_slug":"carmine-stengone","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-24T04:48:05.383419+00:00","sources":[{"id":"alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:30:04.867+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:434fefa119fd890d6372a79e5b99737e46e8ce5c412af8804f4ee76ba9ee3f7f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000040/kprx-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T04:34:48.081955+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1869ac78a81b79697eb5de31e480aa9c176f6c7836cf74af0bd0e032f9202402","identity_scope":"source_document_reference","source_type":"sec_filing","title":"KPRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251426000040/kprx-20260430.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T04:34:48.709709+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.859,"cross_source_agreement":0.75,"temporal_completeness":0.6},"diagnostics":{"published_claims":23,"factual_claims":23,"claims_with_linked_evidence":23,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":15,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-24T04:48:05.383419+00:00","observed_at":"2026-10-24T04:48:05.383419+00:00","reviewed_at":"2026-10-24T04:48:05.383419+00:00","verified_at":"2026-10-24T04:48:05.383419+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/kiora-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}